In The News Posted January 17, 2019 Share Posted January 17, 2019 WESTFIELD, N.J., Jan. 17, 2019 /PRNewswire/ -- Acquist Therapeutics, Inc., a biopharmaceutical company committed to bettering the lives of people with inflammatory diseases, today announced that the U.S. Patent Office has issued two new patents covering the Acquist investigational drug... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.